Optimization of a formulation containing viable lactic acid bacteria

被引:46
作者
Stadler, M [1 ]
Viernstein, H [1 ]
机构
[1] Univ Vienna, Inst Pharmaceut Technol & Biopharmaceut, A-1090 Vienna, Austria
关键词
gastric juice resistant tablets; lactic acid bacteria; formulation;
D O I
10.1016/S0378-5173(03)00068-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the present study, gastric juice resistant tablet formulations of lactic acid bacteria (LAB) were developed, using hydroxypropylmethylcellulose acetate succinate (HPMCAS) as well as alginates, apple pectin and Metolose(R) as matrix forming components. To optimize the formulation-using survival rate in acid medium, and disintegration time in intestinal fluid as test parameters-tablets were modified with respect to LAB content, amount of applied excipients per tablet, and compaction forces. A decrease of viable cells of not more than one log unit after 2 h of incubation in acid medium was desired, as well as a disintegration time of 1 h in phosphate buffer pH 6.8. It was found that the amount of HPMCAS in the tablet correlates with gastric juice resistance. As HPMCAS also leads to a decrease of disintegration time in intestinal fluid, slight amounts of this excipient were preferred. The best protective qualities against artificial gastric juice were observed when tablets were prepared from compaction mixtures of LAB, HPMCAS and sodium alginate. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:117 / 122
页数:6
相关论文
共 12 条
[1]   Effect of fermented milk (yogurt) containing Lactobacillus acidophilus L1 on serum cholesterol in hypercholesterolemic humans [J].
Anderson, JW ;
Gilliland, SE .
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 1999, 18 (01) :43-50
[2]   PREVENTIVE EFFECT OF A LACTOBACILLUS-CASEI PREPARATION ON THE RECURRENCE OF SUPERFICIAL BLADDER-CANCER IN A DOUBLE-BLIND TRIAL [J].
ASO, Y ;
AKAZA, H ;
KOTAKE, T ;
TSUKAMOTO, T ;
IMAI, K ;
NAITO, S .
EUROPEAN UROLOGY, 1995, 27 (02) :104-109
[3]   Yoghurt enriched with Lactobacillus acidophilus does not lower blood lipids in healthy men and women with normal to borderline high serum cholesterol levels [J].
de Roos, NM ;
Schouten, G ;
Katan, MB .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 1999, 53 (04) :277-280
[4]   PROBIOTICS IN HUMAN MEDICINE [J].
FULLER, R .
GUT, 1991, 32 (04) :439-442
[5]  
GILLILAND SE, 1979, J FOOD PROTECT, V42, P164, DOI 10.4315/0362-028X-42.2.164
[6]   Health benefits of probiotics [J].
Goldin, BR .
BRITISH JOURNAL OF NUTRITION, 1998, 80 (04) :S203-S207
[7]  
HALPERN GM, 1991, INT J IMMUNOTHER, V7, P205
[8]   Lactic acid bacteria and the human gastrointestinal tract [J].
Hove, H ;
Norgaard, H ;
Mortensen, PB .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 1999, 53 (05) :339-350
[9]  
Marteau P, 1993, World Rev Nutr Diet, V74, P1
[10]  
MERSCHSUNDERMAN.V, 1998, MED MIKROBIOLOGIE